Home › Myeloproliferative Neoplasms › NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Tissue Procurement For Hematolymphoid Conditions
Who can join
Ages 18 to 120 · All sexes
Full eligibility criteria
DISEASE CHARACTERISTICS: * Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: * Acute myeloid leukemia * Acute lymphoblastic leukemia * Chronic myelogenous leukemia * Chronic lymphoid leukemia * Non-Hodgkin lymphoma * Hodgkin lymphoma * Myelodysplastic syndromes * Myeloproliferative disorders * Multiple myeloma * Waldenstrom macroglobulinemia * Aplastic anemia * Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage * Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified
About the study
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
What is being tested
- biologic sample preservation procedure (other)
- cytology specimen collection procedure (other)
Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 15,000 · Started: 2009-07
Contact the study team
- Paul Armistead, MD · Phone: (919) 843-6847
Official record on ClinicalTrials.gov — NCT01137643
Locations in the U.S.
| North Carolina | Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill |
Conditions
- Myeloproliferative Neoplasms
- Leukemia
- Lymphoma
- Multiple Myeloma
- Plasma Cell Cancer
- Myelodysplastic Syndromes
- Cancer (all types)
- Accelerated Phase Myeloid Leukemia
- Acute Biphenotypic Leukemia
- Birth Defects
- Chronic Myeloid Leukemia
- Blast Crisis
- Prolymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Chronic Lymphocytic Leukemia
- Hairy Cell Leukemia
- Large Granular Lymphocytic Leukemia
- Hodgkin Lymphoma
- Anaplastic Large-Cell Lymphoma
- Immunoblastic Lymphadenopathy
- Cutaneous T-Cell Lymphoma
- Mycosis Fungoides
- Sezary Syndrome
- Extranodal NK-T-Cell Lymphoma
- Waldenstrom Macroglobulinemia
- Marginal Zone Lymphoma
- Burkitt Lymphoma
- Diffuse Large B-Cell Lymphoma
- Non-Hodgkin Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Myelofibrosis
- Essential Thrombocythemia
- Polycythemia Vera
- Immunoglobulin Light-chain Amyloidosis
- Aplastic Anemia
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.